Literature DB >> 20514273

Lisdexamfetamine dimesylate (vyvanse), a prodrug stimulant for attention-deficit/hyperactivity disorder.

David W Goodman.   

Abstract

Entities:  

Year:  2010        PMID： 20514273      PMCID： PMC2873712     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  39 in total

1.  Reliability and validity of the SKAMP rating scale in a laboratory school setting.

Authors:  S B Wigal; S Gupta; D Guinta; J M Swanson
Journal:  Psychopharmacol Bull       Date:  1998

2.  Short-term effects of lisdexamfetamine dimesylate on cardiovascular parameters in a 4-week clinical trial in adults with attention-deficit/hyperactivity disorder.

Authors:  Lenard A Adler; Richard H Weisler; David W Goodman; Mohamed Hamdani; Gwendolyn E Niebler
Journal:  J Clin Psychiatry       Date:  2009-12       Impact factor: 4.384

3.  Medication treatment strategies in the MTA Study: relevance to clinicians and researchers.

Authors:  L L Greenhill; H B Abikoff; L E Arnold; D P Cantwell; C K Conners; G Elliott; L Hechtman; S P Hinshaw; B Hoza; P S Jensen; J S March; J Newcorn; W E Pelham; J B Severe; J M Swanson; B Vitiello; K Wells
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-10       Impact factor: 8.829

Review 4.  Attention-deficit/hyperactivity disorder in adults: an overview.

Authors:  S V Faraone; J Biederman; T Spencer; T Wilens; L J Seidman; E Mick; A E Doyle
Journal:  Biol Psychiatry       Date:  2000-07-01       Impact factor: 13.382

5.  The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm.

Authors:  R C Kessler; M Lane; P E Stang; D L Van Brunt
Journal:  Psychol Med       Date:  2008-04-21       Impact factor: 7.723

6.  Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis.

Authors:  L E Arnold; J Christopher; R Huestis; D J Smeltzer
Journal:  Arch Gen Psychiatry       Date:  1978-04

7.  Comparison of drug adherence rates among patients with seven different medical conditions.

Authors:  Becky A Briesacher; Susan E Andrade; Hassan Fouayzi; K Arnold Chan
Journal:  Pharmacotherapy       Date:  2008-04       Impact factor: 4.705

8.  Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults.

Authors:  Mary B Haffey; Mary Buckwalter; Pinggao Zhang; Robert Homolka; Patrick Martin; Kenneth C Lasseter; James C Ermer
Journal:  Postgrad Med       Date:  2009-09       Impact factor: 3.840

9.  Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers.

Authors:  D R Jasinski; S Krishnan
Journal:  J Psychopharmacol       Date:  2008-07-17       Impact factor: 4.153

10.  Comparing the efficacy of medications for ADHD using meta-analysis.

Authors:  Stephen V Faraone; Joseph Biederman; Thomas J Spencer; Megan Aleardi
Journal:  MedGenMed       Date:  2006-10-05
View more
  11 in total

Review 1.  Amino Acids in the Development of Prodrugs.

Authors:  Nuno Vale; Abigail Ferreira; Joana Matos; Paula Fresco; Maria João Gouveia
Journal:  Molecules       Date:  2018-09-11       Impact factor: 4.411

2.  Phase synchronization of oxygenation waves in the frontal areas of children with attention-deficit hyperactivity disorder detected by optical diffusion spectroscopy correlates with medication.

Authors:  Sharon B Wigal; Chiara M Polzonetti; Annamarie Stehli; Enrico Gratton
Journal:  J Biomed Opt       Date:  2012-12       Impact factor: 3.170

Review 3.  Neuropharmacology of compulsive eating.

Authors:  Catherine F Moore; Julia I Panciera; Valentina Sabino; Pietro Cottone
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-03-19       Impact factor: 6.237

Review 4.  Neural circuit control of innate behaviors.

Authors:  Wei Xiao; Zhuo-Lei Jiao; Esra Senol; Jiwei Yao; Miao Zhao; Zheng-Dong Zhao; Xiaowei Chen; Peng Cao; Yu Fu; Zhihua Gao; Wei L Shen; Xiao-Hong Xu
Journal:  Sci China Life Sci       Date:  2021-12-30       Impact factor: 6.038

Review 5.  Current Pharmacological Treatments for ADHD.

Authors:  Madeleine J Groom; Samuele Cortese
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 6.  Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options.

Authors:  Paul Hodgkins; Monica Shaw; David Coghill; Lily Hechtman
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-07-05       Impact factor: 4.785

7.  Physician perception of clinical improvement in children with attention-deficit/hyperactivity disorder: a post hoc comparison of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in a crossover analog classroom study.

Authors:  Frank A López; Brian Scheckner; Ann C Childress
Journal:  Neuropsychiatr Dis Treat       Date:  2011-05-06       Impact factor: 2.570

Review 8.  A systematic review of the safety of lisdexamfetamine dimesylate.

Authors:  David R Coghill; Beatriz Caballero; Shaw Sorooshian; Richard Civil
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749

Review 9.  Trace Amine Associated Receptor 1 (TAAR1) Modulation of Food Reward.

Authors:  Catherine F Moore; Valentina Sabino; Pietro Cottone
Journal:  Front Pharmacol       Date:  2018-02-27       Impact factor: 5.810

10.  Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling.

Authors:  Josephine Elia; Grace Ungal; Charlly Kao; Alexander Ambrosini; Nilsa De Jesus-Rosario; Lene Larsen; Rosetta Chiavacci; Tiancheng Wang; Christine Kurian; Kanani Titchen; Brian Sykes; Sharon Hwang; Bhumi Kumar; Jacqueline Potts; Joshua Davis; Jeffrey Malatack; Emma Slattery; Ganesh Moorthy; Athena Zuppa; Andrew Weller; Enda Byrne; Yun R Li; Walter K Kraft; Hakon Hakonarson
Journal:  Nat Commun       Date:  2018-01-16       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.